We are live on ! Find out more
MLTX icon

MoonLake Immunotherapeutics
MLTX

136 hedge funds and large institutions have $2.34B invested in MoonLake Immunotherapeutics in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 33 increasing their positions, 43 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $8.78M

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

18% more funds holding

Funds holding: 115 → 136 (+21)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

5.92% less ownership

Funds ownership: 100.57% → 94.65% (-5.9%)

23% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 43

32% less capital invested

Capital invested by funds: $3.43B → $2.34B (-$1.09B)

Holders
136
Holders Change
+21
Holders Change %
+18.26%
% of All Funds
1.82%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
36
Increased
33
Reduced
43
Closed
15
Calls
$21.1M
Puts
$8.78M
Net Calls
+$12.3M
Net Calls Change
+$9.63M

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$15.1M
2
Millennium Management
Millennium Management
New York
+$14.8M
3
OCA
Octagon Capital Advisors
New York
+$12.8M
4
VPC
Vestal Point Capital
New York
+$8.62M
5
Franklin Resources
Franklin Resources
California
+$8.25M

Top Sellers

Rank Fund Capital Flow
1
Holocene Advisors
Holocene Advisors
New York
-$60.2M
2
PBA
Paradigm Biocapital Advisors
New York
-$49.3M
3
Citadel Advisors
Citadel Advisors
Florida
-$30.5M
4
Marshall Wace
Marshall Wace
United Kingdom
-$26M
5
EC
EcoR1 Capital
California
-$18M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
126
Geneos Wealth Management
Colorado
$4.65K -$345 -8 -57%
NNPTE
127
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$3.32K – – –
ACM
128
Aquatic Capital Management
Illinois
$3.2K +$3.53K +82 New
Osaic Holdings
129
Osaic Holdings
Arizona
$2.93K – – –
Carson Wealth (CWM LLC)
130
Carson Wealth (CWM LLC)
Nebraska
$2K +$1.03K +24 +96%
JSAM
131
J. Safra Asset Management
New York
$1.99K +$1.85K +43 +538%
Amundi
132
Amundi
France
$457 – – –
CFD
133
Creative Financial Designs
Indiana
$391 +$431 +10 New
TPCW
134
TD Private Client Wealth
New York
$352 +$388 +9 New
TWD
135
True Wealth Design
Ohio
$157 +$172 +4 New
LC
136
Lindbrook Capital
California
$156 +$172 +4 New
EC
137
EcoR1 Capital
California
– -$18M -332,522 Closed
Adage Capital Partners
138
Adage Capital Partners
Massachusetts
– -$8.39M -155,000 Closed
Alyeska Investment Group
139
Alyeska Investment Group
Illinois
– -$5.42M -100,000 Closed
Point72 Asset Management
140
Point72 Asset Management
Connecticut
– -$5.35M -98,719 Closed
PHP
141
Parkman Healthcare Partners
Connecticut
– -$2.94M -54,294 Closed
UOC
142
UBS O'Connor
Illinois
– -$1.12M -20,740 Closed
CM
143
Caption Management
Oklahoma
– -$533K -12,371 Closed
CCM
144
Cinctive Capital Management
New York
– -$573K -10,576 Closed
YIH
145
Y-Intercept (HK)
Hong Kong
– -$500K -9,229 Closed
Mariner
146
Mariner
Kansas
– -$272K -5,028 Closed
PEAK6
147
PEAK6
Illinois
– -$271K -5,000 Closed
Parallax Volatility Advisers
148
Parallax Volatility Advisers
California
– -$174K -3,208 Closed
VEA
149
Virtus ETF Advisers
New York
– -$71.6K -1,322 Closed
BIG
150
Brooklyn Investment Group
New York
– -$4.22K -78 Closed
3 4 5
6
7

MLTX Hedge Fund Activity: Q1 2025 in Review

136 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in MoonLake Immunotherapeutics (MLTX) for Q1 2025, worth a combined $2.34B — down 32% from $3.43B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new MLTX positions and 15 closed out — a net gain of 21 holders — while 33 added to existing stakes and 43 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $15.1M. The largest seller was Holocene Advisors, cutting an estimated $60.2M.

  • 136 institutional investors held MoonLake Immunotherapeutics (MLTX) as of Q1 2025, up from 115 in Q4 2024.
  • Funds reported $2.34B of MoonLake Immunotherapeutics stock for Q1 2025, down 32% quarter-over-quarter.
  • 36 funds opened new MoonLake Immunotherapeutics positions in Q1 2025 and 15 closed out, a net change of +21 holders.
  • The largest MoonLake Immunotherapeutics buyer in Q1 2025 was Logos Global Management, an estimated $15.1M added.
  • The largest MoonLake Immunotherapeutics seller in Q1 2025 was Holocene Advisors, an estimated $60.2M sold.

Based on aggregated 13F filings for Q1 2025.